Arbutus Biopharma Corp. (ABUS)

4.44 +0.01 (+0.23%) USD  |  NASDAQ  |  Apr 22, 11:47
More

Arbutus Biopharma Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for ABUS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Moderna, Inc. Upgrade
Merck & Co., Inc. Upgrade
Pfizer Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade